What are the next big challenges for the life sciences industry? Which big healthcare issues will be the focus for 2023 and beyond? Where is the next blockbuster coming from and who stands to benefit?

The JP Morgan Healthcare Conference 2023 will cover many of crucial issues for the life sciences sector, from digital health to the regulatory environment and the indications set to take off this year. And that’s before the ever-critical deal making environment and who’s set to invest where.

As always, our Evaluate Vantage team will bring together the highlights, along with context, views and what it really means for biopharma and investors alike. And you can pre-register for it now.